Ms. Mojela to speak at Global Cannabis Partnership Launch in House of Commons
Not for Distribution to U.S. Newswire Servicers or For Dissemination in the United States
Halo Labs Inc. ("Halo" or the "Company") (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce that the Deputy Prime Minister of Lesotho, Mr. Monyane Moleleki will be joining CEO of Halo Labs Kiran Sidhu and Chairman of Bophelo Bioscience Ms. Louisa Mojela at Prohibition Partners Cannabis Europa, IMN’s Inaugural Institutional Capital & Cannabis Conference in Europe (IC3), and other events throughout the week of June 24th 2019.
On Monday June 24th from 6:30-8:30 PM, Ms. Mojela will participate in a panel discussion at the Global Cannabis Partnership European launch in the House of Commons. Ms. Mojela’s panel will explore the cannabis industry’s opportunity to have a uniquely positive impact on society through social justice and environmental sustainability. The Global Cannabis Partnership is an international initiative that seeks to establish corporate social responsibility standards across legal cannabis markets worldwide. A collaboration of leaders from across the cannabis supply chain, GCP members include government agencies charged with the distribution and sale of legal cannabis, licensed cannabis producers, research institutions, and NGOs. The event will take place at the Houses of Parliament, Westminster, London SW1A 0AA.
Ms. Mojela stated, “There is great potential for the African cannabis industry given our continent’s population of over a billion people with abundant land and natural resources. The Kingdom of Lesotho has taken a lead in this and that has positioned Bophelo to take advantage of the growing demand for GMP grade cannabis in the EU and other regions. Beyond the financial opportunity though, the I am excited by the potential this industry has to provide jobs and social benefits to our citizens including educational opportunities to the underprivileged.”
On Tuesday June 25th the Hon. Monyane Moleleki Deputy Prime Minister of Lesotho will deliver a keynote speech at Cannabis Europa. He will be preceded by the Hon. Prime Minister of Malta Joseph Muscat, who will be speaking on the opportunities for economic development and public health improvement allowed by the regulation of medical cannabis. The keynote addresses will take place at Queen Elizabeth Hall (Main Stage) at Southbank Centre Address: Southbank Centre, Belvedere Rd, Lambeth, London SE1 8XX.
Mr. Moleleki commented on his participation stating, “I look forward to discussing the current state of Lesotho’s cannabis industry and how we expect our regulations and legal industry to enable many benefits both social and economic. The cannabis industry is a significant development that should benefit the global cannabis market on the whole. With added strength from Halo Labs and commitment to EU GMP manufacturing, we look forward to the expansion of cultivation, production, and sales originating in our country. We anticipate Bophelo Bioscience to be an economic and socially responsible contributor to Lesotho and to have a positive impact on job creation and local opportunities for our citizens.”
On June 26th Halo Labs will also have a booth located near the entrance to the main session room IC3 which is being held at Liverpool Street - 155 Bishopsgate, London, England EC2M 3YD. Kiran Sidhu will speak on a panel about best practices in due diligence for the cannabis industry.
Halo Labs is proud to sponsor Cannabis Europa as well as the Institutional Capital & Cannabis Conference Europe (IC3 Europe). The IC3 Europe is a meeting place for investors who wish to learn more about this exciting new asset class, as well as cannabis companies and investment funds who are looking to raise money or showcase their products and professional services.
Halo is a cannabis extraction company that develops and manufactures quality cannabis oils and concentrates, which are the fastest growing segments in the cannabis industry. Halo is a global leader in cannabis oil and concentrates and has expertise across as major cannabis manufacturing processes, leveraging proprietary processes and products, and has produced over 4.0M grams of oils and concentrates since inception. The forward-thinking company is led by a strong management team with deep industry knowledge and blue-chip experience. The Company is currently operating in California and Oregon as well as Nevada with our partner Just Quality, LLC and in Lesotho with the Bophelo strategic partnership. With a consumer-centric focus, Halo will continue to market innovative branded and private label products across multiple product categories.
ABOUT BOPHELO BIOSCIENCE
Bophelo Bioscience is based in the Kingdom of Lesotho, Southern Africa and is the holder of one of a limited number of licenses issued in Lesotho for the production of medicinal cannabis products. Situated in proximity 70 kilometers to the capital city of Maseru, the Company’s operating site is an ideal location with ample labor, free water, flat land area, and low crime rates. The favorable high altitude, low humidity climate provides clean and organic growing conditions within the pristine mountainous region. With the motto "Sechaba se tlisa lerou" (community brings wealth), Bophelo highlights the value of community and empowerment of the Basotho people with a focus on the development of women and youth.
Lesotho is the first African country to legalize the cultivation and manufacturing of medicinal cannabis, becoming one of the most sought-after locations for cannabis operations in the world. The country has issued a limited number of licenses since legalization in 2016 and has been exporting cannabis since early 2018.
For further information regarding Halo, see Halo’s disclosure documents on SEDAR at www.sedar.com.
Cautionary Note Regarding Forward-Looking Information and Statements
This press release contains certain "forward-looking information" within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only Halo’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of Halo’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or may contain statements that certain actions, events or results "may", "could", "would", "might" or "will be taken", "will continue", "will occur" or "will be achieved". The forward-looking information and forward-looking statements contained herein may include, but is not limited to, the appointment of Ms. Mojela to the board of directors of the Company, the appointment of Ms. Mojela as Chairman of the board of directors, the closing of the Transaction, the value to be realized by the Company from the appointment of Ms. Mojela, the continued expansion of the Company in the global market, that Ms. Mojela will become the first African woman to lead a publicly traded cannabis company, that Bophelo will continue to provide 10% of its pretax earnings to a trust, that Mr. Paterson will not stand for election at the upcoming annual and special meeting of shareholders, the effect of Ms. Mojela's appointment on women in the cannabis industry and the appointment of Fred Leigh as interim Chairman of the Company's board of directors.
By identifying such information and statements in this manner, Halo is alerting the reader that such information and statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different from those expressed or implied by such information and statements. In addition, in connection with the forward-looking information and forward-looking statements contained in this press release, Halo has made certain assumptions. Although Halo believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and Halo does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws. All subsequent written and oral forward-looking information and statements attributable to Halo or persons acting on its behalf is expressly qualified in its entirety by this notice.